Printer Friendly

Luminex, Merck KGaA's EMD Millipore renew supply, distribution deal.

M2 PHARMA-May 29, 2013-Luminex, Merck KGaA's EMD Millipore renew supply, distribution deal(C)2013 M2 COMMUNICATIONS

29 May 2013 - US biological testing technologies developer Luminex Corp (NASDAQ:LMNX) and EMD Millipore, part of German Merck KGaA (ETR:MRK), have extended their supply and distribution deal, Luminex said yesterday.

Under the deal, EMD Millipore will continue to offer the full range of Luminex's xMAP systems, including MAGPIX, Luminex 100/200, and FLEXMAP 3D.

The US firm added that the agreement facilitates the development of life science and protein assays by EMD Millipore for Luminex's flexible platform.

John Sweeney, head of life sciences business, EMD Millipore, said that the renewal of the contract ensures that EMD Millipore can provide clients with a complete solution for multiplexed protein detection including assay kits, instruments, software and services.

((Comments on this story may be sent to

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:May 29, 2013
Previous Article:Tethys makes its prediabetes PreDx test available with finger stick collection method.
Next Article:Global immunoassay testing market to grow to USD 21bn in 2017.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |